Breaks Categories: News

MondayApr 15, 2024 1:16 pm

NetworkNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Share CLEAR MIND Study Results in Featured Research Oral Presentation at 2024 AAIC

Longeveron (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it has been accepted for a Featured Research Oral Presentation to present the company’s CLEAR MIND Phase 2a study results. A Phase 2a randomized clinical trial, CLEAR-MIND is evaluating Lomecel-B(TM) in mild Alzheimer’s disease. In addition to the study results, Longeveron has been accepted for a poster presentation at the 2024 Alzheimer’s Association International Conference (“AAIC”) taking place online and in Philadelphia, Pennsylvania, from July 28 – August 1, 2024. “We are extremely excited to share the full study results of our CLEAR-MIND trial at the…

Continue Reading

MondayApr 15, 2024 11:32 am

NetworkNewsBreaks – Reunion Gold Releases Report on Infill Drilling Program at Guyana-Based Oko West Project

Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, is reporting on additional drill results from its infill drill program at the Oko West Project. Highlights of the report include Hole D-375 intersecting 60.4 meters (“m”) @ 1.50 grams per tonne of gold (“g/t”) Au, including 6.0 m @ 7.06 g/t, Hole D-381 intersecting 44.9 m @ 2.28 g/t Au, including 18.3 m @ 4.38 g/t Au and Hole D-389 intersecting 21.6 m @4.00 g/t Au, including 4.0m @ 17.67 g/t Au. According to the report, these results continue to expand the core of high-grade…

Continue Reading

MondayApr 15, 2024 10:52 am

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Releases Update on Celly Nu Investment

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, is reporting on its investment in Celly Nutrition Corp. According to the report, FSA entered into a loan-amending agreement with Celly Nu that increased the principal of a previously announced term loan by $300,000, from $1 million to $1.3 million. Celly Nu is a privately held Canadian company launching an innovative beverage product that can assist in expediting alcohol metabolism and faster recovery from alcohol consumption. The announcement noted that the interest…

Continue Reading

MondayApr 15, 2024 10:22 am

NetworkNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Featured in Upcoming New to the Street Episode

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, is featured in the New to the Street TV, episode 569. The episode is scheduled to air on April 22, 2024, at 10:30 p.m. PT on the Fox Business Network. During the episode, the “Sekur Privacy & Sekur Security – Weekly Hack”segment, Sekur Private Data CEO Alain Ghiai, an internet privacy expert, chats with TV host and multimedia journalist Ana Berry about the recent news regarding telecommunication provider AT&T and the data from 73 million current and former customers being stolen by a hacker. According…

Continue Reading

FridayApr 12, 2024 1:49 pm

NetworkNewsBreaks – Upstream Bridges Investment Gap for Issuers

Upstream, a MERJ Exchange market and trading app, today published a blog article that discussed common investment difficulties for issuers and how Upstream Exchange is helping solve these challenges. The article noted that roadshows are a cornerstone of any successful listing, but issuers often face a gap between generating excitement and securing capital from global retail investors. This is because traditional processes make it difficult for global retail investors to access U.S., Canadian and other securities, hindering participation in upcoming offers. “The concept of direct exchange access with an app didn’t exist… until Upstream, a MERJ Exchange market. Upstream gives…

Continue Reading

FridayApr 12, 2024 1:24 pm

NetworkNewsBreaks – Yahoo! Finance Publishes Article on Big Tech-Led Rebound in US Stocks

Yahoo Finance published an article that discussed the U.S. stock surge on Thursday as big tech stocks led a rebound from a sell-off fueled by Wednesday’s surprise uptick in consumer prices. The article noted that members of the “Magnificent 7” tech stocks, a group that includes Apple Inc. (NASDAQ: AAPL), Nvidia Corp. (NASDAQ: NVDA), Amazon.com Inc. (NASDAQ: AMZN), Alphabet Inc. (NASDAQ: GOOGL, GOOG), Microsoft Corp. (NASDAQ: MSFT), Meta Platforms Inc. (NASDAQ: META), and Tesla Inc. (NASDAQ: TSLA), helped lead the rally. “Apple and Nvidia were both up more than 4%, while Amazon gained more than 1.5% to hit its first…

Continue Reading

FridayApr 12, 2024 12:52 pm

NetworkNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Closes on Public Offering Valued at Estimated $5.2M

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has closed on its previously announced public offering. The offering was comprised of up to 2,234,043 shares of Class A LGVN common stock (or prefunded warrants in lieu thereof) and warrants to purchase up to 2,234,043 shares of Class A common stock, both offered at $2.35 per share and associated warrant. The announcement noted that the warrants are exercisable upon issuance for up to five years. The public offering resulted in gross…

Continue Reading

FridayApr 12, 2024 11:37 am

NetworkNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Announces ‘Milestone Achievement’ on Journey to Developing PAX-101

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has completed the execution of three pivotal registration/validation batches of PAX-101, which is an IV formulation of suramin. According to the announcement, this is an important milestone achievement as the company works toward enabling a New Drug Application (“NDA”) submission to the U.S. Food and Drug Administration (“FDA”). Currently, the company anticipates submitting the NDA in Q4 2024; this will mark another key milestone as the company works toward the potential commercial availability in the United States of the first and only form of suramin for the…

Continue Reading

ThursdayApr 11, 2024 3:50 pm

NetworkNewsBreaks – Riley Exploration Permian Inc. (NYSE American: REPX) Closes on $65.2M Public Offering

Riley Exploration Permian (NYSE American: REPX), a growth-oriented, independent oil and natural-gas company, has released the pricing of its previously announced underwritten public offering. The offering is comprised of 2,100,000 shares of common stock at $27 per share; the offering includes 700,000 shares offered by the company and 1,400,000 shares being offered by REPX stockholders. In addition, Riley Permian granted the underwriters a 30-day option to purchase up to 315,000 additional shares of common stock at the public offering price, minus underwriting discounts and commissions. The option was fully exercised. According to the announcement, gross proceeds from the offering, which…

Continue Reading

ThursdayApr 11, 2024 3:34 pm

NetworkNewsBreaks – Boston Hemp Inc Recognized as Nation’s Largest Supplier of Premium, Indoor THCa Flower and Extracts

Boston Hemp, a leading player in the hemp industry, today announced its achievement of being recognized as the nation’s largest supplier of exotic indoor THCa flower and extracts. With a commitment to quality and innovation, Boston Hemp has rapidly emerged as a key player in the thriving market. The company’s dedication to excellence is reflected in its cutting-edge facilities and extraction processes, and Boston Hemp prides itself on delivering premium products to meet the growing demand from consumers seeking high-quality and natural alternatives in all 50 states. “We are thrilled to be recognized as the nation’s largest supplier of premium,…

Continue Reading